About
Eterna Therapeutics Inc (NASDAQ:ERNA) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 20 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
Feb 3 2026
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Jan 27 2026
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Jan 6 2026
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
Financials
Revenue
$1 K
Market Cap
$6.11 M
EPS
-2.24
Google Übersetzer